Literature DB >> 32191793

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Michael J Rybak1, Jennifer Le2, Thomas P Lodise3, Donald P Levine4, John S Bradley5, Catherine Liu6, Bruce A Mueller7, Manjunath P Pai7, Annie Wong-Beringer8, John C Rotschafer9, Keith A Rodvold10, Holly D Maples11, Benjamin M Lomaestro12.   

Abstract

Entities:  

Keywords:  nephrotoxicity; pharmacokinetics and pharmacodynamics; target attainment; vancomycin; vancomycin consensus guideline

Mesh:

Substances:

Year:  2020        PMID: 32191793     DOI: 10.1093/ajhp/zxaa036

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  150 in total

1.  Should Therapeutic Monitoring of Vancomycin Based on Area under the Curve Become Standard Practice for Patients with Confirmed or Suspected Methicillin-Resistant Staphylococcus aureus Infection?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2020-06-01

2.  Performance of Area under the Concentration-Time Curve Estimations of Vancomycin with Limited Sampling by a Newly Developed Web Application.

Authors:  Kazutaka Oda; Yumi Hashiguchi; Toshimi Kimura; Yasuhiro Tsuji; Kensuke Shoji; Yoshiko Takahashi; Kazuaki Matsumoto; Hideki Kawamura; Hideyuki Saito; Yoshio Takesue
Journal:  Pharm Res       Date:  2021-03-29       Impact factor: 4.200

3.  Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Jennifer Le; Thomas Lodise; Donald Levine; John Bradley; Catherine Liu; Bruce Mueller; Manjunath Pai; Annie Wong-Beringer; John C Rotschafer; Keith Rodvold; Holly D Maples; Benjamin M Lomaestro
Journal:  J Pediatric Infect Dis Soc       Date:  2020-07-13       Impact factor: 3.164

4.  A whole blood microsampling assay for vancomycin: development, validation and application for pediatric clinical study.

Authors:  Ganesh S Moorthy; Kevin J Downes; Christina Vedar; Athena F Zuppa
Journal:  Bioanalysis       Date:  2020-09-18       Impact factor: 2.681

5.  The Pharmacodynamic-Toxicodynamic Relationship of AUC and C max in Vancomycin-Induced Kidney Injury in an Animal Model.

Authors:  Sean N Avedissian; Gwendolyn Pais; Jiajun Liu; J Nicholas O'Donnell; Thomas P Lodise; Michael Neely; Walter C Prozialeck; Peter C Lamar; Leighton Becher; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

6.  Effectiveness of Vancomycin Dosing Guided by Therapeutic Drug Monitoring in Adult Patients Receiving Extracorporeal Membrane Oxygenation.

Authors:  Prashanti Marella; Jason Roberts; Karen Hay; Kiran Shekar
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  Impact of the Implementation of a Vancomycin Protocol on Trough Serum Vancomycin Concentrations in a Pediatric Intensive Care Unit.

Authors:  Raíssa Queiroz Rezende; Cícero Armídio Gomes Dias; Claudia Pires Ricachinevsky; João Paulo de Lucena Capelari
Journal:  Paediatr Drugs       Date:  2021-04-08       Impact factor: 3.022

8.  Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation.

Authors:  Younghee Jung; Dong-Hwan Lee; Hyoung Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

9.  Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.

Authors:  Erin Chung; Jonathan Sen; Priya Patel; Winnie Seto
Journal:  Clin Pharmacokinet       Date:  2021-05-18       Impact factor: 6.447

10.  Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.

Authors:  Ahmed A Mahmoud; Sean N Avedissian; Abbas Al-Qamari; Tiffany Bohling; Michelle Pham; Marc H Scheetz
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.